Brain-behavior Associations of Sensorimotor Therapy Post Stroke

Overview

Stroke survivors often encounter impairments in the upper limb after stroke. Sensorimotor impairments are present in 67% of the stroke patients, resulting in problems with independency and performance of activities of daily life. In addition, the pattern of recovery in the brain is still a matter of ongoing debate. Although the importance of somatosensory function on motor performance is well described, evidence for somatosensory or sensorimotor therapy and brain-related changes is scares. Therefore, we aim to explore the effect of a sensorimotor therapy compared to pure motor therapy on motor function of the upper limb. A second objective is to investigate therapy-induced brain-behavior associations using resting state functional Magnetic Resonance Imaging of the brain.

Full Title of Study: “Behavioral and Brain Connectivity Analysis of Upper Limb Sensorimotor Rehabilitation Post Stroke: a Randomized Controlled Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: December 1, 2017

Detailed Description

Stroke survivors often encounter impairments in the upper limb after stroke. Sensorimotor impairments are present in 67% of the stroke patients, resulting in problems with independency and performance of activities of daily life. In addition, the pattern of recovery in the brain is still a matter of ongoing debate. Although the importance of somatosensory function on motor performance is well described, evidence for somatosensory or sensorimotor therapy and brain-related changes is scares. Therefore, will conduct a Randomized Controlled Trial with three main objectives. The first objective of this project is to investigate the effect of sensorimotor therapy on motor function of the upper limb. To achieve this objective, a sensorimotor program will be developed based on the SENSE therapy. Patients will be randomly allocated to either the sensorimotor therapy group or the pure motor therapy group; and will receive 16 hours of therapy. Motor and Somatosensory assessments will be performed at three time points: baseline(admission to rehabilitation center), immediately after the 16 hours of therapy and after 4 weeks of follow-up. The second objective is to investigate therapy-induced brain-behavior associations with resting state functional connectivity. In order to achieve insights in brain-behavior associations, we will perform resting-state functional Magnetic Resonance Imaging (fMRI) scans at the same time points as the clinical assessments: baseline, immediately after the 16 hours of therapy, and four weeks after the end of the therapy. Both measurements, brain-imaging and clinical measurements will be combined to investigate the associations. This project will lead to new insights in brain-behavior associations of sensorimotor function of the upper limb after stroke and will provide evidence for a new therapy in upper limb stroke rehabilitation.

Interventions

  • Other: additional sensorimotor therapy for the upper limb
    • The intervention will consist of additional physiotherapy for the upper limb after stroke consisting of sensory discrimination training and sensorimotor training.
  • Other: additional motor therapy for the upper limb after stroke
    • The intervention will consist of additional physiotherapy for the upper limb after stroke consisting of cognitive-attention based training and motor training

Arms, Groups and Cohorts

  • Experimental: sensorimotor therapy
    • sensorimotor therapy will consist of 30minutes of sensory discrimination training and 30 minutes of sensorimotor training per session. The sensory discrimination training is based on on the SENSe training of Carey et all. The sensorimotor training is the same individually tailored motor therapy as described below, but with integration of sensory discrimination training aspects.
  • Active Comparator: motor therapy
    • The motor therapy consists of 30 minutes of cognitive and attention-based table top games and 30 minutes of motor training per session. The cognitive-attention-based therapy consists of table top games such as chess, rush hour, or other smart games. Individually tailored motor therapy consists of a unilateral motor exercise program for the upper limb, while seated at a table, under supervision of a therapist to match the therapy and intensity provided in the other sensorimotor therapy group. This 30 minutes of motor arm training is based on a set of standardized exercises which comprise task-related practice for gross movements and dexterity including different grips and selective finger movements, and training in daily life activities, however without any attention to sensory discrimination training.

Clinical Trial Outcome Measures

Primary Measures

  • Action Research Arm Test
    • Time Frame: within 4 months post stroke
    • grasp, grip, pinch and gross movement of the affected arm and hand

Secondary Measures

  • Fugl-Meyer motor Assessment-upper Extremity
    • Time Frame: within 4 months post stroke
    • overall motor impairment of the affected upper limb: shoulder, arm, wrist , hand and fingers
  • composite standardized somatosensory deficit index
    • Time Frame: within 4 months post stroke
    • composite standardized score consisting of fabric matching test, wrist position sense test and functional tactile object recognition test
  • Erasmus modified Nottingham Sensory Assessment
    • Time Frame: within 4 months post stroke
    • light touch, pressure, sharp, sharp-dull discrimination, position sense of the arm and hand
  • Perceptual Threshold of Touch
    • Time Frame: within 4 months post stroke
    • threshold of light touch determined with Transcutaneous Electric Nerve Stimulation at the index finger.
  • Nine Hole Peg test
    • Time Frame: within 4 months post stroke
    • manual dexterity
  • Stroke Upper Limb Capacity Scale
    • Time Frame: within 4 months post stroke
    • upper limb capacity by the means of ten functional and meaningful tasks related to daily live activities
  • functional connectivity
    • Time Frame: within 4 months post stroke
    • resting-state fMRI functional connectivity between Regions of Interest of the sensorimotor network

Participating in This Clinical Trial

Inclusion Criteria

  • first ever stroke as defined by the WHO (world health organisation) criteria – assessed and included within 8 weeks after stroke onset – unilateral motor impairment in the upper limb (ARAT <52/56) – unilateral somatosensory impairment in the upper limb (SSD <0.00) – minimally 18 years old – substantially cooperation to perform the assessments and therapy – written informed consent Exclusion Criteria:

  • musculoskeletal and/or other neurological disorders such as previous stroke, head injuries, multiple sclerosis of Parkinson's disease – a subdural hematoma, tumor, encephalitis or trauma that lead to similar symptoms as a stroke – severe communication deficits – severe cognitive deficits – the presence of contra-indications for proceeding an MRI scan such as defibrillator, pacemaker or metal prosthesis ( as defined in the MRI checklist of Radiology UZ Leuven)

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Universitaire Ziekenhuizen KU Leuven
  • Collaborator
    • Research Foundation Flanders
  • Provider of Information About this Clinical Study
    • Principal Investigator: Geert Verheyden, Professor – Universitaire Ziekenhuizen KU Leuven
  • Overall Official(s)
    • Geert Verheyden, Principal Investigator, KU Leuven

Citations Reporting on Results

Carey L, Macdonell R, Matyas TA. SENSe: Study of the Effectiveness of Neurorehabilitation on Sensation: a randomized controlled trial. Neurorehabil Neural Repair. 2011 May;25(4):304-13. doi: 10.1177/1545968310397705. Epub 2011 Feb 24.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.